ALGN
Get informed when a big investor buys or sells
+ FollowOvervalued by 39.1% based on the discounted cash flow analysis.
| Market cap | $10.98 Billion |
|---|---|
| Enterprise Value | $11.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.66 |
| Beta | 1.67 |
| Outstanding Shares | 71,460,000 |
| P/E Ratio | 26.82 |
|---|---|
| PEG | -204.89 |
| Price to Sales | 2.71 |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 2.71 |
| Enterprise Value to EBIT | 19.63 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 133.57% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 5.76%▼ 97.01% |
|---|---|
| Total Invested | $596.87M▼ 95.15% |
| Investors Holding | 120▼ 589.00% |
No data
Align Technology, Inc., a prominent medical device company, is dedicated to developing, producing, and commercializing innovative solutions for dental professionals. Its core offerings include the well-known Invisalign clear aligner syst...